Net profits soared to EGP 32.5 million last year from EGP 18 million in 2018, the company said in a statement to the Egyptian Exchange (EGX) on Monday.
Meanwhile, the company’s sales surged to EGP 523 million in the 12-month period ended 31 December 2019, compared to EGP 400.6 million a year earlier.
It is noteworthy that during the January-September period of 2019, October Pharma’s net profits rose to EGP 19 million, up from EGP 16 million in the year-ago period.
All Rights Reserved - Mubasher Info © 2005 - 2020 Provided by SyndiGate Media Inc. (Syndigate.info).




















